Clp-targeting BacPROTACs impair mycobacterial proteostasis and survival.

BacPROTAC Clp protease ClpC1 Mycobacterium tuberculosis antibiotics cyclomarin A ecumicin protein quality control small-molecule degrader targeted protein degradation

Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
11 05 2023
Historique:
received: 11 10 2022
revised: 24 02 2023
accepted: 05 04 2023
medline: 15 5 2023
pubmed: 4 5 2023
entrez: 3 5 2023
Statut: ppublish

Résumé

The ClpC1:ClpP1P2 protease is a core component of the proteostasis system in mycobacteria. To improve the efficacy of antitubercular agents targeting the Clp protease, we characterized the mechanism of the antibiotics cyclomarin A and ecumicin. Quantitative proteomics revealed that the antibiotics cause massive proteome imbalances, including upregulation of two unannotated yet conserved stress response factors, ClpC2 and ClpC3. These proteins likely protect the Clp protease from excessive amounts of misfolded proteins or from cyclomarin A, which we show to mimic damaged proteins. To overcome the Clp security system, we developed a BacPROTAC that induces degradation of ClpC1 together with its ClpC2 caretaker. The dual Clp degrader, built from linked cyclomarin A heads, was highly efficient in killing pathogenic Mycobacterium tuberculosis, with >100-fold increased potency over the parent antibiotic. Together, our data reveal Clp scavenger proteins as important proteostasis safeguards and highlight the potential of BacPROTACs as future antibiotics.

Identifiants

pubmed: 37137307
pii: S0092-8674(23)00404-X
doi: 10.1016/j.cell.2023.04.009
pii:
doi:

Substances chimiques

Antitubercular Agents 0
Bacterial Proteins 0
Endopeptidase Clp EC 3.4.21.92
Heat-Shock Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2176-2192.e22

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests K.F., V.M.S., K.R., H.W., and G.B. were employees of Boehringer Ingelheim at the time of this work.

Auteurs

David M Hoi (DM)

Research Institute of Molecular Pathology, Vienna BioCenter, 1030 Vienna, Austria; Max Perutz Labs, Vienna BioCenter, 1030 Vienna, Austria; Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, 1030 Vienna, Austria; University of Vienna, Center for Molecular Biology, Department for Biochemistry and Cell Biology, 1030 Vienna, Austria.

Sabryna Junker (S)

Research Institute of Molecular Pathology, Vienna BioCenter, 1030 Vienna, Austria.

Lukas Junk (L)

Saarland University, Organic Chemistry I, 66123 Saarbrücken, Germany; Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), 66123 Saarbrücken, Germany. Electronic address: lukas.junk@helmholtz-hips.de.

Kristin Schwechel (K)

Institute of Pharmaceutical Biology and Biotechnology, Heinrich Heine University, 40225 Düsseldorf, Germany.

Katharina Fischel (K)

Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.

David Podlesainski (D)

University of Duisburg-Essen, Center of Medical Biotechnology, Faculty of Biology, 45141 Essen, Germany.

Paige M E Hawkins (PME)

School of Chemistry, University of Sydney, Sydney, NSW 2006, Australia; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, NSW 2006, Australia.

Lasse van Geelen (L)

Institute of Pharmaceutical Biology and Biotechnology, Heinrich Heine University, 40225 Düsseldorf, Germany.

Farnusch Kaschani (F)

University of Duisburg-Essen, Center of Medical Biotechnology, Faculty of Biology, 45141 Essen, Germany.

Julia Leodolter (J)

Research Institute of Molecular Pathology, Vienna BioCenter, 1030 Vienna, Austria.

Francesca Ester Morreale (FE)

Research Institute of Molecular Pathology, Vienna BioCenter, 1030 Vienna, Austria.

Stefan Kleine (S)

University of Duisburg-Essen, Center of Medical Biotechnology, Faculty of Biology, 45141 Essen, Germany.

Somraj Guha (S)

Saarland University, Organic Chemistry I, 66123 Saarbrücken, Germany.

Klaus Rumpel (K)

Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.

Volker M Schmiedel (VM)

Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.

Harald Weinstabl (H)

Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.

Anton Meinhart (A)

Research Institute of Molecular Pathology, Vienna BioCenter, 1030 Vienna, Austria.

Richard J Payne (RJ)

School of Chemistry, University of Sydney, Sydney, NSW 2006, Australia; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, NSW 2006, Australia.

Markus Kaiser (M)

University of Duisburg-Essen, Center of Medical Biotechnology, Faculty of Biology, 45141 Essen, Germany.

Markus Hartl (M)

Max Perutz Labs, Vienna BioCenter, 1030 Vienna, Austria; University of Vienna, Center for Molecular Biology, Department for Biochemistry and Cell Biology, 1030 Vienna, Austria.

Guido Boehmelt (G)

Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.

Uli Kazmaier (U)

Saarland University, Organic Chemistry I, 66123 Saarbrücken, Germany; Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), 66123 Saarbrücken, Germany.

Rainer Kalscheuer (R)

Institute of Pharmaceutical Biology and Biotechnology, Heinrich Heine University, 40225 Düsseldorf, Germany.

Tim Clausen (T)

Research Institute of Molecular Pathology, Vienna BioCenter, 1030 Vienna, Austria; Medical University of Vienna, 1030 Vienna, Austria. Electronic address: tim.clausen@imp.ac.at.

Articles similaires

Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria

Two codependent routes lead to high-level MRSA.

Abimbola Feyisara Adedeji-Olulana, Katarzyna Wacnik, Lucia Lafage et al.
1.00
Methicillin-Resistant Staphylococcus aureus Penicillin-Binding Proteins Peptidoglycan Bacterial Proteins Anti-Bacterial Agents
Deep Learning RNA, Bacterial RNA, Small Untranslated Mycobacterium tuberculosis Computational Biology
Mycobacterium tuberculosis Animals Guinea Pigs Bacterial Proteins Toxin-Antitoxin Systems

Classifications MeSH